Prices delayed by at least 15 minutes | Print
Haleon PLC (HLN)
ORD GBP0.01Open
336.60p
Previous close
336.20p
Trade high
337.60p
Volume
23,434,653
Year high
416.10p
Year low
274.40p
Dividend yield
2.19%
Market capitalisation
£29.36 bn
P/E ratio
18.44
ISIN
GB00BMX86B70
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 10/04/2026 | 14/08/2026 |
| Ex-dividend date | 09/04/2026 | 13/08/2026 |
| Payment date | 14/05/2026 | 17/09/2026 |
| Amount | 4.90p | 2.40p |
Company profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of salesfrom global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 11/09/2026 | 04:38:28 | 333.8 | 83,818 | 279,784.48 |
| 11/09/2026 | 04:38:28 | 333.8 | 17,099 | 57,076.46 |
| 11/09/2026 | 04:35:57 | 333.8 | 2,163 | 7,220.09 |
| 11/09/2026 | 04:35:18 | 333.8 | 6,691,287 | 22,335,516.01 |
| 11/09/2026 | 04:29:43 | 333.8 | 114 | 380.53 |